230 related articles for article (PubMed ID: 10770414)
1. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM
Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN
Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036
[TBL] [Abstract][Full Text] [Related]
3. Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study.
Laurés AS; Gomez E; Alvarez V; Coto E; Baltar J; Alvarez-Grande J
Transplant Proc; 2003 Aug; 35(5):1739-41. PubMed ID: 12962777
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy.
Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M
Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.
Arnadottir M; Hultberg B; Vladov V; Nilsson-Ehle P; Thysell H
Transplantation; 1996 Feb; 61(3):509-12. PubMed ID: 8610370
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.
Herrero JI; Quiroga J; Sangro B; Beloqui O; Pardo F; Cienfuegos JA; Prieto J
Liver Transpl; 2000 Sep; 6(5):614-8. PubMed ID: 10980061
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia in renal transplant recipients with cyclosporine.
Kim SI; Yoo TH; Song HY; Hwang JH; Lee HY; Han DS; Moon JI; Kim YS; Park KI; Paeng KJ; Choi KH
Transplant Proc; 2000 Nov; 32(7):1878-9. PubMed ID: 11119981
[No Abstract] [Full Text] [Related]
9. Homocysteine and C-reactive protein levels in haemodialysis patients.
Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I
Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
11. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
[TBL] [Abstract][Full Text] [Related]
12. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
13. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
14. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
15. Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.
Polkinghorne KR; Zoungas S; Branley P; Villanueva E; McNeil JJ; Atkins RC; McGrath BP; Kerr PG
Intern Med J; 2003 Nov; 33(11):489-94. PubMed ID: 14656250
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid.
Patel AV; Morgan SL; Green R; Danila MI; Merriman TR; Wanzeck K; Ahmed H; Gaffo AL
Am J Med Sci; 2024 Jul; 368(1):33-39. PubMed ID: 38561045
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia and schizophrenia: case control study].
Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
[TBL] [Abstract][Full Text] [Related]
19. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients.
Cole DE; Ross HJ; Evrovski J; Langman LJ; Miner SE; Daly PA; Wong PY
Clin Chem; 1998 Nov; 44(11):2307-12. PubMed ID: 9799758
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
